GeneDx Holdings Corp.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | +2.3% | +51.3% | -119.6% | – | – | – | |
| – | -22.8% | -21.6% | -0.6% | +214.2% | -134.2% | – | +9.0% | +4.6% | +6.3% | -1.0% | -1.4% | – | |
| – | -312.1% | – | – | +17.0% | -21.8% | +40.0% | +96.2% | +35.5% | -7.6% | -8.0% | -29.5% | – | |
| – | – | – | – | – | – | – | -587.6% | – | – | -8,940.5% | – | – | |
| – | +2,021.4% | -81.4% | +205.2% | -52.2% | +372.1% | +101.0% | -61.3% | +160.5% | -29.6% | +48.4% | +56.7% | – | |
| – | -82.2% | – | -2,792.9% | -65.8% | -93.3% | +1,712.7% | +286.4% | -87.1% | +136.2% | +55.8% | -67.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +116.1% | -40.4% | -6.4% | +42.6% | -43.9% | +8,542.5% | – | – | |
| – | – | -100.9% | -10.7% | – | +122.1% | -55.8% | -97.5% | +3,012.1% | +115.4% | +66.4% | -97.4% | – | |
| – | – | -230.2% | – | – | +1,402.8% | -47.0% | -276.5% | – | -58.7% | -222.6% | – | – | |
| – | – | – | – | – | – | – | +98.6% | +19.2% | -177.5% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.